1Hagai Ligumsky,Ido Wolf,Shira Israeli,Michal Haimsohn,Sarah Ferber,Avraham Karasik,Bella Kaufman,Tami Rubinek.The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells[J].Breast Cancer Research and Treatment.2012(2)
2Scott D A,Boye K S,Timlin L,et al.A network meta-anal-ysis to compare glycaemic control in patients with type 2 diabetes treatedwith exenatide once weekly or liraglutide once daily in comparison withinsulin glargine,exenatide twice daily or placebo[].Diabetes Obesity and Metabolism.2012
3Madsbad S,Kielgast U,Asmar M,et al.An overview of once-weekly glucagon-like peptide-1 receptor agonists--available ef-ficacy and safety data and perspectives for the future[].Diabetes ObesMetab.2011
4CURRIE C J,POOLE C D,GALE E A,et a1.The influence ofglucose-lowering therapies on cancer risk in type 2 diabetes[].Diabetologia.2009
5Koehler J A,Kain T,Drucker D J.Glucagon-like peptide-1 recep-tor activation inhibits growth and augments apoptosis in murinect26 colon cancer cells[].The Journal of Endocrinology.2011
6Chiu W Y,Shih S R,Tseng C H.A review on the associationbetween glucagon-like peptide-1 receptor agonists and thyroid canc-er[].Exp Diabetes Res.2012
7Tseng C H,Chen C J,Landolph J J.Diabetes and cancer:epidemiological,clinical,and experimental perspectives[].Exp DiabetesRes.2012
8Koole C,Wootten D,Simms J,et al.Second extracellularloop of human glucagon-like peptide-1 receptor (GLP-1R)has acritical role in GLP-1 peptide binding and receptor activation[].Journal of Biolchemistics.2012
9Samson S L.Direct actions of GLP-1 analogues on AMP-ac-tivated Protein Kinase activity are distinct from cyclic AMP accumula-tion[].Journal of Hepatology.2012
10Mamtani R,Haynes K,Bilker W B,et al.Association be-tween longer therapy with thiazolidinediones and risk of bladder cancer:a cohort study[].Journal of the National Cancer Institute.2012
9SONG Yang1,2, GAO Zhong-li2, DU Zhen-wu1, PIAO Song-lan1, WANG Ling-ling1, WANG Qing3 and ZHANG Gui-zhen1 1. Central Research Department, 2. Department of Orthopaedics, 3. Department of Endocrinology, China-Japan Union Hospital of Jilin University, Changchun 130033, P. R. China.Molecular Targets of Combined Natural Antioxidants Against Diabetes in Streptozotocin-induced Diabetic Mice[J].Chemical Research in Chinese Universities,2012,28(1):96-102.
